Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on perinatal HIV transmission.

M G Fowler1, R J Simonds, A Roongpisuthipong

  • 1Pediatric and Adolescent Studies Section, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. mgf1@cdc.gov

Pediatric Clinics of North America
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>China CDC Weekly</i>- A Step Forward for China's Public Health System and for Global Health Security.

China CDC weekly·2021
Same author

Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe.

AIDS and behavior·2019
Same author

Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries.

Journal of acquired immune deficiency syndromes (1999)·2014
Same author

A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance.

Journal of acquired immune deficiency syndromes (1999)·2014
Same author

Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study.

ISRN AIDS·2014
Same author

The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.

African health sciences·2013
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Antiretroviral drugs like Zidovudine (ZDV) significantly reduce mother-to-child HIV transmission. Translating these findings into global public health policy is crucial, especially in resource-limited areas.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Virology

Background:

  • Perinatal HIV transmission remains a significant global health challenge.
  • Understanding risk factors and timing of transmission has advanced significantly.
  • Clinical trials have identified effective antiretroviral interventions.

Purpose of the Study:

  • To highlight the success of antiretroviral interventions in reducing perinatal HIV transmission.
  • To emphasize the need for implementing these interventions in resource-poor settings.
  • To address the ongoing challenge of HIV transmission during breastfeeding.

Main Methods:

  • Review of clinical trials involving antiretroviral drugs such as Zidovudine (ZDV), ZDV-3TC, and nevirapine.
  • Analysis of the impact of these trials on reducing infant HIV infection rates.

Related Experiment Videos

  • Examination of public health policy implementation in the United States and Europe.
  • Main Results:

    • Antiretroviral therapies have demonstrated significant reductions in infant HIV infection risk.
    • Rapid implementation of trial results has led to dramatic decreases in new perinatal HIV cases in developed countries.
    • Nearly 600,000 neonates are still infected annually through mother-infant transmission in resource-poor settings.

    Conclusions:

    • Successful antiretroviral strategies for preventing perinatal HIV transmission are established.
    • Urgent translation of short-course antiretroviral regimens into public health policy for resource-limited settings is imperative.
    • Further research is needed to develop strategies to minimize HIV transmission during breastfeeding.